Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!
https://www.thehindubusinessline.com/markets/stock-markets/biocon-shares-decline-despite-analyst-optimism-on-biologics-merger-deal/article70371607.ece Copy Biocon ...
Hosted on MSN
Top Breakout Stock Ideas: Analysts Pick Biocon, KFin Tech, Poly Medicure, Sammaan Capital And More
SEBI-registered analysts have identified breakout opportunities in seven stocks with strong technical charts and rising volumes. From Biocon and KFin Technologies to Poly Medicure, Bajaj Consumer, ...
Biocon share price jumped over 4% to a fresh 52-week high on Thursday after reports stated that the company was evaluating an internal merger of its biosimilars arm, Biocon Biologics, with the parent ...
The shares of Biocon dropped 3 percent on December 8 as analysts cautioned investors about equity dilution after the company fully acquires its subsidiary Biocon Biologics. The shares of the company ...
Biocon shares will be in focus on Tuesday after the biotechnology major announced the opening of its Qualified Institutions Placement (QIP) issue post-market hours on January 12, 2026. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results